logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Carmela Pisano

Invalid input
H指数:38
被引数:4,766
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and molecular heterogeneity in advanced-stage POLE-mutated endometrial carcinoma: a focus on aggressive subsets and co-mutations

POLE突变晚期子宫内膜癌的临床和分子异质性：聚焦于侵袭性亚组和共突变

Frontiers in Oncology
IF3.3
2026-04-290
OA
NC Nicolo Cavasin; SK Sami Kilzie; MV Mattia Vinci; RT Rita Trozzi; CN Camilla Nero; SR Stefano Restaino; CC Chiara Cassani; SP Sandro Pignata; CP Carmela Pisano; GS Giuseppe Scibilia; RF Robert Fruscio; RM Rosanna Mancari; AF Adolfo Favaretto; MF Matteo Fassan; LT Luisa Toffolatti; GG Giovanna Gallina; FF Francesco Fanfani; VS Vanda Salutari; GA Grazia Artioli
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25)

新诊断晚期卵巢癌患者接受奥拉帕尼联合贝伐珠单抗维持治疗（PAOLA-1/ENGOT-ov25）的健康相关生活质量

JNCI: Journal of the National Cancer Institute
IF0
2026-04-240
OA
Florence Joly, MD, PhD; Amélie Anota, PhD; Sylvie Chabaud, MSc; Claire Cropet, MSc; Frank Priou, MD; Philipp Harter, MD, PhD; Sandro Pignata, MD, PhD; Isabel Palacio, MD; Edgar Petru, MD; Hiroaki Kobayashi, MD; Ignace Vergote, MD, PhD; Gabriella Parma, MD; Johanna Mäenpää, MD, PhD; Eric Raymond, MD; Beyhan Ataseven, MD; Carmela Pisano, MD; Nuria Lainez, MD; Irina Tsibulak, MD; Kan Yonemori, MD; Peter Vuylsteke, MD; Maria Teresa Lapresa, MD; Mansoor Raza Mirza, MD; Patrick Bouchaert, MD; Paul Buderath, MD; Domenica Lorusso, MD, PhD; Ana Herrero, MD; Lauriane Eberst, MD; Alexander Burges, MD; Giovanni Scambia, MD, PhD; Eugenia Ortega, MD; Cécile Guillemet, MD; Eric Pujade-Lauraine, MD, PhD; Jean-Emmanuel Kurtz, MD, PhD; Isabelle Ray-Coquard, MD, PhD; null
KELIM score: A marker of chemosensitivity in ovarian cancer

KELIM评分：卵巢癌化疗敏感性的标志物

Cancer Treatment Reviews
IF10.5
2025-12-180
PRE
Federica Adele Ambrosino; Carmela Pisano; Marilena Di Napoli; Jole Ventriglia; Rosa Tambaro; Sabrina Rossetti; Anna Passarelli; Ernesta Cavalcanti; Rossella De Cecio; Francesco Fiore; Sergio Venanzio Setola; Teresa Troiani; Lorenzo Lobianco; Erica Perri; Mariarosaria Lamia; Gabriele Calvanese; Sandro Pignata; Sabrina Chiara Cecere
Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial

高级别子宫内膜癌中的同源重组修复状态：来自随机、II期MITOEND 3试验的探索性生物标志物分析

ESMO Open
IF8.3
2025-12-050
OAAI
M. Bartoletti; A. Passarelli; A. Fagotti; C. Andreetta; S. Tamberi; D. Lorusso; C. Pisano; D. Califano; A. Spina; C. De Angelis; F. Greco; R. De Cecio; G.L. Scaglione; D. Russo; V. Ghizzoni; S. Cinieri; S.D. Sisoudiya; E.S. Sokol; L. Arenare; C. Schettino
The Impact of body mass index on Survival and Surgical Outcomes in Ovarian Cancer: Insights from the MITO Trials

体重指数对卵巢癌患者生存及手术结果的影响：来自MITO试验的见解

International Journal of Gynecological Cancer
IF4.7
2025-11-010
PRE
Teresa Di Lauro; Ilaria De Benedictis; Paolo Chiodini; Francesco Perrone; Laura Arenare; Francesco Raspagliesi; Sabrina Chiara Cecere; Innocenza Palaia; Vittoria Carbone; Maria Grazia Di Stefano; Roberto Bianco; Carmela Pisano; Michele Bartoletti; Antonella Savarese; Clorinda Schettino; Davide Limongello; Maria Giovanna Mormile; Elisabetta Coppola; Sandro Pignata
Peripheral Thyroid Hormones, Inflammatory and Skeletal Muscle Indexes in Advanced Cervical Cancer Treated With Cemiplimab

Cemiplimab治疗晚期宫颈癌的外周血甲状腺激素，炎症和骨骼肌指标

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
IF9.1
2025-10-010
OAAI
Tuninetti, Valentina; Virano, Elisa; Calvo, Amedeo; Carbone, Vittoria; Pisano, Carmela; Ducceschi, Monika; Turitto, Giacinto; Scandurra, Giuseppa; Petrella, Maria Cristina; Forestieri, Valeria; Petracchini, Massimo; Bianco, Alessandra; Cioffi, Raffaella; Mantiero, Mara; Paluzzi, Eleonora; Distefano, Maria Grazia; Martelli, Olga; Pignata, Sandro; Formica, Vincenzo; Loupakis, Fotios; Valabrega, Giorgio
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin plus paclitaxel/avelumab (MITO-END3 trial)

外周单核细胞源性抑制性细胞与单中心接受卡铂联合紫杉醇/阿维单抗治疗子宫内膜癌患者分子亚型的相关性（MITO-END3试验）

CANCER IMMUNOLOGY IMMUNOTHERAPY
IF5.1
2025-04-170
OA
D'Alterio, C.; Rea, G.; Napolitano, M.; Coppola, E.; Spina, A.; Russo, D.; Azzaro, R.; Mignogna, C.; Scognamiglio, G.; Califano, D.; Arenare, L.; Schettino, C.; Pisano, C.; Cecere, S. C.; Di Napoli, M.; Passarelli, A.; Perrone, F.; Pignata, S.; Scala, S.
Homologous Recombination Repair Status In Advanced Endometrial Cancer. An Exploratory Biomarker Analysis From The Randomized, Phase II MITO END 3 Trial

高级子宫内膜癌的同源重组修复状态。来自随机、II期MITO END 3试验的探索性生物标志物分析

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2025-02-010
PRE
Bartoletti, Michele; Farolfi, Alberto; Passarelli, Anna; Scambia, Giovanni; Andreetta, Claudia; Tamberi, Stefano; Lorusso, Domenica; Pisano, Carmela; Califano, Daniela; De Angelis, Carmine; Greco, Filippo; De Cecio, Rossella; Scaglione, Giovanni Luca; Spina, Anna; Ghizzoni, Viola; Cinieri, Saverio; Arenare, Laura; Schettino, Clorinda; Perrone, Franco; Pignata, Sandro
The Role Of POLE Mutational Status In Endometrial Cancer: A MITO POLE-END Observational Study

POLE突变状态在子宫内膜癌中的作用：一项MITO POLE-END观察性研究

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2025-02-010
PRE
Artioli, Grazia; Giannarelli, Diana; Cavasin, Nicolo; Restaino, Stefano; Fruscio, Robert; Legge, Francesco; Baldoni, Alessandra; Cassani, Chiara; Alberto, Daniele; Mancari, Rosanna; Chiari, Rita; D'Asta, Marco; Amico, Paolo; Carella, Claudia; Pisano, Carmen; Tuninetti, Valentina; Frezzi, Simona
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial
ESMO OPEN
IF8.3
2025-01-011
OAAI
Pellegrino, B.; Capoluongo, E. D.; Bagnoli, M.; Arenare, L.; Califano, D.; Scambia, G.; Cecere, S. C.; Silini, E. M.; Scaglione, G. L.; Spina, A.; Tognon, G.; Campanini, N.; Pisano, C.; Russo, D.; Pettinato, A.; Scollo, P.; Iemmolo, R.; De Cecco, L.; Musolino, A.; Marchini, S.; Beltrame, L.; Paracchini, L.; Perrone, F.; Mezzanzanica, D.; Pignata, S.
Endometrial cancer in the elderly: Characteristics, prognostic and risk factors, and treatment options
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
IF5.6
2024-12-014
PRE
Forte, Miriam; Cecere, Sabrina Chiara; Di Napoli, Marilena; Ventriglia, Jole; Tambaro, Rosa; Rossetti, Sabrina; Passarelli, Anna; Casartelli, Chiara; Rauso, Martina; Alberico, Gennaro; Mignogna, Chiara; Fiore, Francesco; Setola, Sergio Venanzio; Troiani, Teresa; Pignata, Sandro; Pisano, Carmela
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ ENGOT-OV26/GOG-3012 trial

新诊断晚期卵巢癌患者的尼拉帕尼一线维持治疗: PRIMA/ ENGOT-OV26/GOG-3012试验的最终总生存期结果

ANNALS OF ONCOLOGY
IF65.4
2024-11-012
OAAI
Monk, B. J.; Barretina-Ginesta, M. P.; Pothuri, B.; Vergote, I.; Graybill, W.; Mirza, M. R.; Mccormicky, C. C.; Lorusso, D.; Moore, R. G.; Freyer, G.; O'Cearbhaill, R. E.; Heitz, F.; O'Malley, D. M.; Redondo, A.; Shahin, M. S.; Vulsteke, C.; Bradley, W. H.; Haslund, C. A.; Chase, D. M.; Pisano, C.; Holman, L. L.; Perez, M. J. Rubio; Disilvestro, P.; Gaba, L.; Herzog, T. J.; Bruchim, I.; Compton, N.; Shtessel, L.; Malinowska, I. A.; Gonzalez-Martin, A.
Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer
CLINICAL THERAPEUTICS
IF3.6
2024-08-010
PRE
Monk, Bradley J.; Romero, Ignacio; Graybill, Whitney; Churruca, Cristina; O'Malley, David M.; Knudsen, Anja or; Yap, Oi Wah Stephanie; Baurain, Jean-Francois; Rose, Peter G.; Denys, Hannelore; Ghamande, Sharad; Pisano, Carmela; Fabbro, Michel; Braicu, Elena Ioana; Calvert, Paula M.; Amit, Amnon; Prendergast, Emily; Taylor, Adekemi; Kheibarshekan, Leila; Zhang, Zhi-Yi; Zajic, Stefan; Jewell, Roxanne C.; Gupta, Divya; Gonzalez-Martin, Antonio
Harmonization of homologous recombination deficiency testing in ovarian cancer: Results from the MITO16A/MaNGO-OV2 trial
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-07-010
PRE
Roma, Cristin; Abate, Riziero Esposito; Sacco, Alessandra; Califano, Daniela; Arenare, Laura; Bergantino, Francesca; Pisano, Carmela; Cecere, Sabrina Chiara; Scambia, Giovanni; Lorusso, Domenica; Artioli, Grazia; Tasca, Giulia; Spina, Anna; Russo, Daniela; Gadducci, Angiolo; De Angelis, Carmine; Bologna, Alessandra; Marchini, Sergio; Capoluongo, Ettore Domenico; Perrone, Francesco; Pignata, Sandro; Normanno, Nicola
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy
ANNALS OF ONCOLOGY
IF65.4
2024-07-014
PRE
Pignata, S.; Califano, D.; Lorusso, D.; Arenare, L.; Bartoletti, M.; De Giorgi, U.; Andreetta, C.; Pisano, C.; Scambia, G.; Lombardi, D.; Farolfi, A.; Cinieri, S.; Passarelli, A.; Salutari, V.; De Angelis, C.; Mignogna, C.; Priolo, D.; Capoluongo, E. D.; Tamberi, S.; Scaglione, G. L.; Arcangeli, V.; De Cecio, R.; Scognamiglio, G.; Greco, F.; Spina, A.; Turinetto, M.; Russo, D.; Carbone, V.; Casartelli, C.; Schettino, C.; Perrone, F.
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-05-010
PRE
Tuninetti, Valentina; Virano, Elisa; Salutari, Vanda; Ricotti, Andrea; Pisano, Carmela; Ducceschi, Monika; Turitto, Giacinto; Scandurra, Giuseppa; Petrella, Maria Cristina; Forestieri, Valeria; Rizzetto, Monica; Mammoliti, Serafina; Artioli, Grazia; Cioffi, Raffaella; Borsotti, Lucia; Bellero, Marco; Rognone, Chiara; Carbone, Vittoria; Ferrandina, Gabriella; Mantiero, Mara; Azzolina, Carmen; Geninatti, Eleonora; Pignata, Sandro; Valabrega, Giorgio
Plasma tumor fraction is an independent prognostic marker of response to front line chemotherapy in high-grade serous epithelial ovarian cancer: The MITO-16a/MANGOOV2a/clinical trial experience
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Marchini, Sergio; Paracchini, Lara; Arenare, Laura; Scambia, Giovanni; Pisano, Carmela; Zadro, Riccardo; Mannarino, Laura; Ferrero, Annamaria; Chiodini, Paolo; Califano, Daniela; Pignata, Sandro; D'Incalci, Maurizio
Untargeted analysis of plasma tumor fraction is an independent prognostic marker of response to front line chemotherapy in high-grade serous epithelial ovarian cancer: the MITO-16A/MANGO-OV2A clinical trial experience
CANCER RESEARCH
IF16.6
2024-03-040
PRE
Marchini, Sergio; Paracchini, Lara; Arenare, Laura; Scambia, Giovanni; Pisano, Carmela; Zadro, Riccardo; Mannarino, Laura; Ferrero, Annamaria; Chiodini, Paolo; Califano, Daniela; Di Gennaro, Piergiacomo; Pignata, Sandro; D'Incalci, Maurizio
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors (vol 13, 1247291, 2023)
FRONTIERS IN ONCOLOGY
IF3.3
2024-01-220
OAAI
Arezzo, Francesca; Giannone, Gaia; Castaldo, Daniele; Scotto, Giulia; Tuninetti, Valentina; Turinetto, Margherita; Bartoletti, Michele; Mammoliti, Serafina; Artioli, Grazia; Mangili, Giorgia; Salutari, Vanda; Lorusso, Domenica; Cormio, Gennaro; Loizzi, Vera; Zamagni, Claudio; Savarese, Antonella; Di Maio, Massimo; Ronzino, Graziana; Pisano, Carmela; Pignata, Sandro; Valabrega, Giorgio
Complete and early response to cemiplimab associated to severe immune toxicity in advanced cervical cancer: a case report
FRONTIERS IN IMMUNOLOGY
IF5.9
2023-12-130
OAAI
Passarelli, Anna; Pisano, Carmela; Coppola, Elisabetta; Ventriglia, Jole; Cecere, Sabrina Chiara; Di Napoli, Marilena; Carideo, Luciano; Lastoria, Secondo; Pignata, Sandro

研究方向

暂未获取到该数据
S
Sandro Pignata
H 指数:81论文数:901被引数:3.5万
S
Sabrina Chiara Cecere
H 指数:31论文数:164被引数:3,026
G
Giovanni Scambia
H 指数:117论文数:3,225被引数:9.0万
D
Daniela Califano
H 指数:34论文数:148被引数:3,653
L
Laura Arenare
H 指数:20论文数:102被引数:1,536
M
Marilena Di Napoli
H 指数:25论文数:164被引数:2,374
D
Domenica Lorusso
H 指数:77论文数:968被引数:3.7万
A
Anna Passarelli
H 指数:19论文数:60被引数:1,301
M
Michele Bartoletti
H 指数:22论文数:123被引数:1,399
A
Anna Spina
H 指数:15论文数:55被引数:703